Par Drugs & Che.

	2019 ( ₹ in Cr. )	2018 ( ₹ in Cr. )	2017 ( ₹ in Cr. )	2016 ( ₹ in Cr. )
INCOME :
Sales Turnover	46.32	42.38	48.77	33.26
Other Income	0.09	0.04	0.04	0.04
Stock Adjustments	0	0.01	-1.48	1.56
Total Income	46.41	42.43	47.33	34.86
EXPENDITURE :
Raw Materials	19.22	17.94	19.59	14.42
Excise Duty	0	0	0	0
Power and Fuel Cost	8.9	6.94	8.45	6.21
Other Manufacturing Expenses	4.37	4.66	5.6	3.49
Employee Cost	2.21	2.04	1.84	1.79
Selling and Administration Expenses	3.41	2.81	3.3	1.72
Miscellaneous Expenses	0.02	0.01	0.05	0.01
Less: Preoperative Expenditure Capitalised	0	0	0	0
Profit before Interest, Depreciation and Tax	8.28	8.02	8.5	7.23
Interest and Financial Charges	1.96	2.33	2.5	3.57
Profit before Depreciation and Tax	6.32	5.69	6	3.66
Depreciation	3.04	3.14	2.82	2.65
Profit Before Tax	3.28	2.56	3.19	1.01
Tax	0.86	1.06	1.34	0.59
Profit After Tax	2.42	1.5	1.85	0.42
Adjustment below Net Profit	0	0	0	0
P and L Balance brought forward	12.15	10.65	8.8	8.38
Appropriations	0	0	0	0
P and L Bal. carried down	14.56	12.15	10.65	8.8
Equity Dividend	0	0	0	0
Preference Dividend	0	0	0	0
Corporate Dividend Tax	0	0	0	0
Equity Dividend (%)	0	0	0	0
Earning Per Share (Rs.)	5.4	5.54	6.84	1.56
Book Value	64.99	55.37	49.83	42.98
Extraordinary Items	0	0	0.01	0

2019 ( ₹ in Cr. )

2018 ( ₹ in Cr. )

2017 ( ₹ in Cr. )

2016 ( ₹ in Cr. )

INCOME :

Sales Turnover

46.32

42.38

48.77

33.26

Other Income

0.09

0.04

Stock Adjustments

0.01

-1.48

1.56

Total Income

46.41

42.43

47.33

34.86

EXPENDITURE :

Raw Materials

19.22

17.94

19.59

14.42

Excise Duty

Power and Fuel Cost

8.9

6.94

8.45

6.21

Other Manufacturing Expenses

4.37

4.66

5.6

3.49

Employee Cost

2.21

2.04

1.84

1.79

Selling and Administration Expenses

3.41

2.81

3.3

1.72

Miscellaneous Expenses

0.02

0.01

0.05

0.01

Less: Preoperative Expenditure Capitalised

Profit before Interest, Depreciation and Tax

8.28

8.02

8.5

7.23

Interest and Financial Charges

1.96

2.33

2.5

3.57

Profit before Depreciation and Tax

6.32

5.69

3.66

Depreciation

3.04

3.14

2.82

2.65

Profit Before Tax

3.28

2.56

3.19

1.01

Tax

0.86

1.06

1.34

0.59

Profit After Tax

2.42

1.5

1.85

0.42

Adjustment below Net Profit

P and L Balance brought forward

12.15

10.65

8.8

8.38

Appropriations

P and L Bal. carried down

14.56

12.15

10.65

8.8

Equity Dividend

Preference Dividend

Corporate Dividend Tax

Equity Dividend (%)

Earning Per Share (Rs.)

5.4

5.54

6.84

1.56

Book Value

64.99

55.37

49.83

42.98

Extraordinary Items

0.01

	2019 ( ₹ in Cr. )	2018 ( ₹ in Cr. )	2017 ( ₹ in Cr. )	2016 ( ₹ in Cr. )
SOURCES OF FUNDS :
Share Capital	4.48	8.45	8.45	8.45
Reserves and Surplus	24.64	12.25	10.75	8.91
Total Shareholders Funds	29.12	20.7	19.2	17.36
Secured Loans	7.78	13.5	15.67	22.76
Unsecured Loans	4.13	9.89	9.38	8.17
Total Debt	11.91	23.39	25.05	30.93
Total Liabilities	41.03	44.09	44.25	48.29
APPLICATION OF FUNDS :
Gross Block	56.71	56.36	55.73	54.13
Less: Accum. Depreciation	20.37	17.33	14.19	11.53
Net Block	36.34	39.03	41.54	42.6
Capital Work in Progress	0	0	0	0
Investments	0.06	0.06	0.06	0.06
Current Assets, Loans and Advances
Inventories	4.29	4.07	3.99	5.58
Sundry Debtors	8.52	8.72	8.11	7.38
Cash and Bank Balance	0.03	0.06	0.02	0.93
Loans and Advances	2.22	2.28	3.13	2.75
Less: Current Liab. and Prov.
Current Liabilities	9.57	9.47	11.79	10.69
Provisions	0.87	0.67	0.79	0.32
Net Current Assets	4.62	4.99	2.67	5.63
Miscellaneous Expenses not w/o	0	0	0	0
Total Assets	41.02	44.08	44.27	48.29
Contingent Liabilities	0.2	0.2	0.18	0.17

2019 ( ₹ in Cr. )

2018 ( ₹ in Cr. )

2017 ( ₹ in Cr. )

2016 ( ₹ in Cr. )

SOURCES OF FUNDS :

Share Capital

4.48

8.45

Reserves and Surplus

24.64

12.25

10.75

8.91

Total Shareholders Funds

29.12

20.7

19.2

17.36

Secured Loans

7.78

13.5

15.67

22.76

Unsecured Loans

4.13

9.89

9.38

8.17

Total Debt

11.91

23.39

25.05

30.93

Total Liabilities

41.03

44.09

44.25

48.29

APPLICATION OF FUNDS :

Gross Block

56.71

56.36

55.73

54.13

Less: Accum. Depreciation

20.37

17.33

14.19

11.53

Net Block

36.34

39.03

41.54

42.6

Capital Work in Progress

Investments

0.06

Current Assets, Loans and Advances

Inventories

4.29

4.07

3.99

5.58

Sundry Debtors

8.52

8.72

8.11

7.38

Cash and Bank Balance

0.03

0.06

0.02

0.93

Loans and Advances

2.22

2.28

3.13

2.75

Less: Current Liab. and Prov.

Current Liabilities

9.57

9.47

11.79

10.69

Provisions

0.87

0.67

0.79

0.32

Net Current Assets

4.62

4.99

2.67

5.63

Miscellaneous Expenses not w/o

Total Assets

41.02

44.08

44.27

48.29

Contingent Liabilities

0.2

0.18

0.17

Par Drugs & Che.

Enjoy Lifetime Free Delivery Trade